GZ-793A

 

Topic mentions per year

Topic mentions per year

2011-2018
02420112018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Methamphetamine is a potent psychostimulant with high abuse rates. Currently, there is no Food and Drug Administration-approved… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Lobeline and lobelane inhibit the behavioral and neurochemical effects of methamphetamine via an interaction with the vesicular… (More)
Is this relevant?
Review
2014
Review
2014
Methamphetamine abuse escalates, but no approved therapeutics are available to treat addicted individuals. Methamphetamine… (More)
Is this relevant?
2013
2013
Despite the high prevalence of use of methamphetamine (METH), there is no FDA-approved pharmacological treatment available… (More)
Is this relevant?
2013
2013
Vesicular monoamine transporter-2 (VMAT2) inhibitors reduce methamphetamine (METH) reward in rats. The current study determined… (More)
Is this relevant?
2013
2013
(R)-3-[2,6-cis-Di(4-methoxyphenethyl)piperidin-1-yl]propane-1,2-diol (GZ-793A) inhibits methamphetamine-evoked dopamine release… (More)
Is this relevant?
2013
2013
Central heterocyclic ring size reduction from piperidinyl to pyrrolidinyl in the vesicular monoamine transporter-2 (VMAT2… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
The vesicular monoamine transporter 2 (VMAT2) has been identified as a potential target for the treatment of methamphetamine… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Previous research suggests that the vesicular monoamine transporter-2 (VMAT2) is a novel target for the treatment of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2011
2011
Lobelane, a chemically defunctionalized saturated analog of lobeline, has increased selectivity for the vesicular monoamine… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?